Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Fusion Pharmaceuticals In...

    NASDAQ: FUSN · Real-Time Price · USD
    21.55
    0.03 (0.14%)
    At close: Jun 03, 2024, 10:00 PM

    Fusion Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 2.07M 1.46M 1.44M
    Cost of Revenue
    		 1.34M 58.9M 56.36M
    Gross Profit
    		 723K -57.43M -54.92M
    Operating Income
    		 -99.23M -88.03M -82.02M
    Interest Income
    		 9.53M 2.16M 381K
    Pretax Income
    		 -94.11M -89.45M -81.17M
    Net Income
    		 -94.9M -87.61M -81.05M
    Selling & General & Admin
    		 31.2M 30.6M 27.1M
    Research & Development
    		 68.76M 58.9M 56.36M
    Other Expenses
    		 762K -1.77M 469K
    Operating Expenses
    		 99.95M 89.5M 83.45M
    Interest Expense
    		 5.17M 1.8M n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a
    Cost & Expenses
    		 101.3M 89.5M 83.45M
    Income Tax Expense
    		 787K -1.84M -118K
    Shares Outstanding (Basic)
    		 65.61M 43.75M 42.6M
    Shares Outstanding (Diluted)
    		 65.61M 43.75M 42.6M
    EPS (Basic)
    		 -1.45 -2 -1.9
    EPS (Diluted)
    		 -1.45 -2 -1.9
    EBITDA
    		 -97.89M -87.65M -81.38M
    EBIT
    		 -88.94M -87.65M -82.02M
    Depreciation & Amortization
    		 1.34M 386K 634K

    Add to Watchlist